[go: up one dir, main page]

AU2003208703A1 - Difurylglycolic acid tropenol esters used as anticholinesterase drugs - Google Patents

Difurylglycolic acid tropenol esters used as anticholinesterase drugs

Info

Publication number
AU2003208703A1
AU2003208703A1 AU2003208703A AU2003208703A AU2003208703A1 AU 2003208703 A1 AU2003208703 A1 AU 2003208703A1 AU 2003208703 A AU2003208703 A AU 2003208703A AU 2003208703 A AU2003208703 A AU 2003208703A AU 2003208703 A1 AU2003208703 A1 AU 2003208703A1
Authority
AU
Australia
Prior art keywords
formula
difurylglycolic
acid
quaternized
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003208703A
Inventor
Gerd Morschhauser
Michael P. Pieper
Georg Speck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Boehringer Ingelheim Pharma GmbH and Co KG
Boehringer Ingelheim Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma GmbH and Co KG, Boehringer Ingelheim Pharmaceuticals Inc filed Critical Boehringer Ingelheim Pharma GmbH and Co KG
Publication of AU2003208703A1 publication Critical patent/AU2003208703A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06Oxygen atoms
    • C07D451/10Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Lubricants (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Quaternized difurylglycolic acid 8-azabicyclo (3.2.1) octyl ester derivatives (I), and individual optical isomers, enantiomer mixtures and racemates, are new. Quaternized difurylglycolic acid 8-azabicyclo (3.2.1) octyl esters derivatives of formula (I), and individual optical isomers, enantiomer mixtures and racemates, are new. A = CH2CH2, CH=CH or oxirane-2,3-diyl; X- = anion with a single negative charge, preferably chloride, bromide, iodide, sulfate, phosphate, methanesulfonate, nitrate, maleate, acetate, citrate, fumarate, tartrate, oxalate, succinate, benzoate or p-toluenesulfonate; R = H, OH, Me, Et, CF3, CHF2 or F; R1, R2 = 1-5C alkyl (optionally substituted by 3-6C cycloalkyl, OH or halogen); or R1+R2 = 3-5C alkylene; and R3, R31 = furyl (optionally substituted by 1-3 of 1-4C alkyl, 1-4C alkoxy, OH, CF3, CN, NO2 or halo). Independent claims are also included for: (1) new non-quaternized intermediates of formula (IV), optionally in the form of their acid addition salts; and (2) the use of azabicyclic alcohols of formula (IV) (optionally in the form of their acid addition salts) in the production of a compound of formula (II).
AU2003208703A 2002-03-16 2003-03-10 Difurylglycolic acid tropenol esters used as anticholinesterase drugs Abandoned AU2003208703A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10211700A DE10211700A1 (en) 2002-03-16 2002-03-16 New quaternized difurylglycolic acid azabicycloalkyl esters, useful as anticholinergic agents for treating e.g. asthma, chronic obstructive pulmonary disease, arrhythmia or menstrual disorders
DE10211700.4 2002-03-16
PCT/EP2003/002418 WO2003078428A1 (en) 2002-03-16 2003-03-10 Difurylglycolic acid tropenol esters used as anticholinesterase drugs

Publications (1)

Publication Number Publication Date
AU2003208703A1 true AU2003208703A1 (en) 2003-09-29

Family

ID=27771378

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003208703A Abandoned AU2003208703A1 (en) 2002-03-16 2003-03-10 Difurylglycolic acid tropenol esters used as anticholinesterase drugs

Country Status (8)

Country Link
EP (1) EP1487831B1 (en)
JP (1) JP2005520832A (en)
AT (1) ATE341547T1 (en)
AU (1) AU2003208703A1 (en)
CA (1) CA2476746A1 (en)
DE (2) DE10211700A1 (en)
ES (1) ES2272947T3 (en)
WO (1) WO2003078428A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080065318A (en) * 2003-10-14 2008-07-11 글락소 그룹 리미티드 Muscarinic Acetylcholine Receptor Antagonists
US20080027094A1 (en) * 2004-08-30 2008-01-31 Ono Pharmaceutical Co., Ltd. Tropane Compounds and Pharmaceutical Compositions Comprising the Same as an Active Ingredient

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
DE4108393A1 (en) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg NEW ESTERS BI-AND TRICYCLIC AMINO ALCOHOLS, THEIR PREPARATION AND THEIR USE IN MEDICINAL PRODUCTS

Also Published As

Publication number Publication date
EP1487831B1 (en) 2006-10-04
EP1487831A1 (en) 2004-12-22
DE10211700A1 (en) 2003-09-25
ATE341547T1 (en) 2006-10-15
DE50305263D1 (en) 2006-11-16
WO2003078428A1 (en) 2003-09-25
JP2005520832A (en) 2005-07-14
CA2476746A1 (en) 2003-09-25
ES2272947T3 (en) 2007-05-01

Similar Documents

Publication Publication Date Title
IL162416A0 (en) Method for producing scopine esters
DE50103666D1 (en) CRYSTALLINE MONOHYDRATE OF TIOTROPIUM BROMIDE, METHOD FOR THE PRODUCTION THEREOF AND ITS USE IN THE PRODUCTION OF A MEDICAMENT
CA2471578A1 (en) Xanthene-carboxylic acid esters of tropenol and scopine as m3 antagonists, method for producing the same and use thereof as medicaments
JP2005516067A5 (en)
UY25225A1 (en) PLEUROMUTILINE DERIVATIVES USEFUL AS ANTIMICROBIAL AGENTS
HRP20080140T3 (en) Aerosol formulation for inhalation, containing an anticholinergic agent
NO943093L (en) Process for the preparation of clavulanic acid
CA2061607A1 (en) 1-biphenylimidazole derivatives, their preparation and their therapeutic use
CO6170341A2 (en) AEROSOL FORMULATION CONTAINING BENZOXAZIN-3ONAS DERIVATIVES
EA200401142A1 (en) MICRONIZED CRYSTALLINE TIOTROPYBROMID
CN107892211A (en) A kind of take-up mechanism for cable production
AR039404A1 (en) COMBINATIONS OF MEDICINES CONTAINING HETEROCICLICAL COMPOUNDS AND AN ANTI-POLINERGIC AGENT. AEROSOL FOR YOUR INHALATION
MY137045A (en) Medicaments comprising steroids and a novel anticholinergic
AU2003208703A1 (en) Difurylglycolic acid tropenol esters used as anticholinesterase drugs
AU2003222290A1 (en) Novel ester hydroxy-substituted nitrogen heterocycles as antagonists of the muscarinic m3 receptor, methods for the production thereof, and use thereof as a medicament
ZA200409676B (en) Novel drug compositions based on novel anticholinergics and inhibitors of EGFR-kinase
CN103182751B (en) A kind of multi-line cutting machine coiling head and cutting machine
AR062476A1 (en) BETA - ENTIMERICALLY PURE AGONISTS, PROCEDURES FOR THEIR PREPARATION AND USE AS MEDICATIONS
RU2018127822A (en) METHOD FOR PRODUCING ISOTOPE
CN210618536U (en) Adhesive filling equipment
CN221567798U (en) High-efficient spraying device of building
GB1120186A (en) Cyclohexene amino acid derivatives and process for their preparation
CN223687737U (en) A winding device for a stretch film machine
CN216723891U (en) Fixing device for indoor furniture
CN222366764U (en) Cordyceps militaris cultivation device

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase